4.60 (-%)
As of Nov 21, 2024
Source:
Verve Therapeutics, Inc.is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | (978) 501-3026 |
| Industry | |
| CEO | Sekar Kathiresan |
| Website | http://www.vervetx.com |